The International Academy of Compounding Pharmacists Introduces a New President

A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

LEARN MORE

The International Academy of Compounding Pharmacists Introduces a New President

Author(s): Rice Baylor

Issue: Mar/Apr 2017 - Volume 21, Number 2
View All Articles in Issue

Page(s): 116-117

The International Academy of Compounding Pharmacists Introduces a New President Page 1

The International Academy of Compounding Pharmacists Introduces a New President Page 2

Download in electronic PDF format for $65

Abstract:

Related Keywords: Baylor Rice, RPh, FIACP, IACP, U.S. Food and Drug Administration, FDA, pharmacy regulation, Drug Quality and Security Act, DQSA Coalition, office-use compounding, Pharmacy Compouding Advisory Committee, 503A sterile compounding pharmacies, legislators, government advocacy, U.S. Congress, lobbying, Compounders on Capitol Hill

Related Categories: LEGAL, PROFESSIONAL ISSUES

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
The International Academy of Compounding Pharmacists Introduces a New President Rice Baylor	Mar/Apr 2017 Pg. 116-117
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr	Jul/Aug 2016 Pg. 351 View Sample
U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies Yoch Doug	Mar/Apr 2017 Pg. 95-102
PreScription: Drug Quality and Security Act Implementation Subcommittee Hearing Allen Loyd V Jr	Mar/Apr 2018 Pg. 92
Standing Together Fixing the Drug Quality and Security Act Miller David G	Mar/Apr 2015 Pg. 104-106
Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1 Allen Loyd V Jr	Sep/Oct 2015 Pg. 389-390
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Allen Loyd V Jr	Sep/Oct 2017 Pg. 356
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Allen Loyd V Jr	Nov/Dec 2015 Pg. 487-488
Applying Quality of Design Concepts to Pharmacy Compounding Timko Robert J	Nov/Dec 2015 Pg. 453-463
Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies Pritchett Jon, McCrory Gary, Kraemer Cheri, Jensen Brenda, Allen Loyd V Jr	Jan/Feb 2018 Pg. 7-16

Particle Measuring Systems - USP <797> Environmental Monitoring Solutions